Financials Medimi AB

Equities

MEDIMI

SE0001860511

Medical Equipment, Supplies & Distribution

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
0.0188 SEK +9.30% Intraday chart for Medimi AB -6.00% -43.03%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 80.77 31.42 77.15 113.2 104.2 39.75
Enterprise Value (EV) 1 64.33 20.46 58.03 107.4 91.55 29.1
P/E ratio -5.8 x -2.8 x -6.37 x -8.33 x -6.37 x -2.58 x
Yield - - - - - -
Capitalization / Revenue - 12,049,122,316 x 66,131,399 x 233,090,864 x 97,378,724 x 19,239,490 x
EV / Revenue - 7,844,513,804 x 49,744,103 x 221,108,875 x 85,575,006 x 14,085,434 x
EV / EBITDA -3.52 x -1.33 x -4.85 x -8 x -5.71 x -2.07 x
EV / FCF -7.57 x -1.7 x -9.48 x -13 x -8.7 x -2.5 x
FCF Yield -13.2% -58.9% -10.5% -7.71% -11.5% -39.9%
Price to Book 5.96 x 2.95 x 3.56 x 13.9 x 6.83 x 2.61 x
Nbr of stocks (in thousands) 84,131 112,229 221,069 221,069 290,198 509,651
Reference price 2 0.9600 0.2800 0.3490 0.5120 0.3590 0.0780
Announcement Date 3/29/18 3/20/19 2/29/20 4/6/21 3/1/22 3/29/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - 0.002608 1.167 0.4856 1.07 2.066
EBITDA 1 -18.28 -15.41 -11.96 -13.41 -16.05 -14.09
EBIT 1 -18.34 -15.46 -12.11 -13.58 -16.34 -15.35
Operating Margin - -592,783.7% -1,037.7% -2,795.86% -1,527.73% -743.02%
Earnings before Tax (EBT) 1 -18.59 -15.5 -12.12 -13.59 -16.36 -15.41
Net income 1 -18.59 -15.5 -12.12 -13.59 -16.36 -15.41
Net margin - -594,485.58% -1,038.71% -2,798.32% -1,529.45% -745.73%
EPS 2 -0.1656 -0.1000 -0.0548 -0.0615 -0.0564 -0.0302
Free Cash Flow 1 -8.501 -12.04 -6.123 -8.274 -10.52 -11.62
FCF margin - -461,767.68% -524.79% -1,703.98% -983.61% -562.57%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/18 3/20/19 2/29/20 4/6/21 3/1/22 3/29/23
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 16.4 11 19.1 5.82 12.6 10.6
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -8.5 -12 -6.12 -8.27 -10.5 -11.6
ROE (net income / shareholders' equity) -116% -93.9% -66.2% -91.2% -140% -101%
ROA (Net income/ Total Assets) -59.7% -50.1% -38.7% -50.7% -72.6% -53.7%
Assets 1 31.16 30.97 31.34 26.78 22.53 28.7
Book Value Per Share 2 0.1600 0.0900 0.1000 0.0400 0.0500 0.0300
Cash Flow per Share 2 0.1500 0.0700 0.0900 0.0300 0.0400 0.0200
Capex - - 0.51 0.29 0.64 3.44
Capex / Sales - - 43.71% 58.91% 59.46% 166.44%
Announcement Date 3/29/18 3/20/19 2/29/20 4/6/21 3/1/22 3/29/23
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW